Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sargent

Showing results (311-320 of 433) with videos related to

Pageof 44
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) DatabaseManish A Shah, Lindsay A Renfro, Carmen J Allegra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2005
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741T Delaunoit, S R Alberts, D J Sargent, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trialRobert C Miller, Daniel J Sargent, James A Martenson, et al.
Current Colorectal Cancer Reports|September 14, 2013
The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current StatusThierry André, Timothy Iveson, Roberto Labianca, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Jeffrey A Sloan, Daniel J Sargent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancerJeff A Sloan, Richard M Goldberg, Daniel J Sargent, et al.
Journal of the American College of Surgeons|April 30, 2013
Current use and surgical efficacy of laparoscopic colectomy in colon cancerRobert P Sticca, Steven R Alberts, Michelle R Mahoney, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2003
A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancerJames A Martenson, Antonio P G Vigliotti, Henry C Pitot, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance)Claire L Jansson-Knodell, Nathan R Foster, Daniel J Sargent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2013
Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapyFrank A Sinicrope, Michelle R Mahoney, Thomas C Smyrk, et al.
Pageof 44

Showing results (311-320 of 433) with videos related to

Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) DatabaseManish A Shah, Lindsay A Renfro, Carmen J Allegra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2005
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741T Delaunoit, S R Alberts, D J Sargent, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trialRobert C Miller, Daniel J Sargent, James A Martenson, et al.
Current Colorectal Cancer Reports|September 14, 2013
The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current StatusThierry André, Timothy Iveson, Roberto Labianca, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Jeffrey A Sloan, Daniel J Sargent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancerJeff A Sloan, Richard M Goldberg, Daniel J Sargent, et al.
Journal of the American College of Surgeons|April 30, 2013
Current use and surgical efficacy of laparoscopic colectomy in colon cancerRobert P Sticca, Steven R Alberts, Michelle R Mahoney, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2003
A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancerJames A Martenson, Antonio P G Vigliotti, Henry C Pitot, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance)Claire L Jansson-Knodell, Nathan R Foster, Daniel J Sargent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2013
Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapyFrank A Sinicrope, Michelle R Mahoney, Thomas C Smyrk, et al.
Pageof 44